Synthetic biology company Intrexon said it acquired GT Life Sciences as well as Cyntellect's LEAP high throughput cell analysis and laser-based cell manipulation technology. Intrexon simultaneously launched its Cell Engineering Unit (CEU) to support the...

The biotechnology industry has long ignored troublesome, endemic diseases of developing countries such as malaria. But the ever-increasing number of airline travelers who become infected during trips and the appearance of previously foreign diseases in...